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Abstract
Background: Our purpose was to study the association between the intracranial atherosclerosis
as measured by cavernous carotid artery calcification (ICAC) observed on head CT and atrophic
changes of supra-tentorial brain demonstrated by MRI.
Methods:  Institutional review board approval was obtained for this retrospective study
incorporating 65 consecutive patients presenting acutely who had both head CT and MRI. Arterial
calcifications of the intracranial cavernous carotids (ICAC) were assigned a number (1 to 4) in the
bone window images from CT scans. These 4 groups were then combined into high (grades 3 and
4) and low calcium (grades 1 and 2) subgroups. Brain MRI was independently evaluated to identify
cortical and central atrophy. Demographics and cardiovascular risk factors were evaluated in
subjects with high and low ICAC. Relationship between CT demonstrated ICAC and brain atrophy
patterns were evaluated both without and with adjustment for cerebral ischemic scores and
cardiovascular risk factors.
Results: Forty-six of the 65 (71%) patients had high ICAC on head CT. Subjects with high ICAC
were older, and had higher prevalence of hypertension, diabetes, coronary artery disease (CAD),
atrial fibrillation and history of previous stroke (CVA) compared to those with low ICAC. Age
demonstrated strong correlation with both supratentorial atrophy patterns. There was no
correlation between ICAC and cortical atrophy. There was correlation however between central
atrophy and ICAC. This persisted even after adjustment for age.
Conclusion: Age is the most important determinant of atrophic cerebral changes. However, high
ICAC demonstrated age independent association with central atrophy.
Introduction
Gradual loss of cerebral tissue in adulthood leads to atro-
phy in the central nervous system. There may be predilec-
tion for atrophy by location such as the infra- vs. supra-
tentorial compartments. In the supra-tentorial compart-
ment, cortical or central atrophy types have been recog-
nized [[1,2] and [4]]. Although age is the most important
determinant of cerebral atrophy [4], variety of other exter-
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nal or internal factors such as local, systemic or humoral
can affect the location, degree and rate of developing atro-
phy [1,5]. Considering the aging population across the
globe, these risk factors are intense focus of research.
Although the role of cardiovascular risk factors [6] and
even extra-cranial atherosclerosis [[7,8] and [9]] on cere-
bral atrophy has been studied, the impact of intracranial
atherosclerosis on atrophy has not been as well evaluated.
This has been largely due to difficulty in accurately grad-
ing the degree of atherosclerosis. Arterial calcium meas-
ured by CT has been recently demonstrated to be a reliable
marker for atherosclerosis. Qualitative or quantitative
measurement of arterial calcium has been utilized to
determine the coronary plaque burden [10-15]. Specifi-
cally, the role of intracranial carotid arterial calcium on
ischemic cerebral changes has been evaluated in different
studies. Cerebral atrophy has not been the focus of atten-
tion in these studies however [16,17].
In this study, we wanted to evaluate the effects of intra-cra-
nial atherosclerosis on supra-tentorial cerebral atrophy
patterns. Specifically, we wanted to explore this link by
incorporating stroke imaging data [16]. Our first aim was
to evaluate possible link between carotid arterial calcium
and cerebral atrophy. Second aim of the study was to eval-
uate whether this link was due to underlying ischemic cer-
ebral changes identifiable by imaging studies or a separate
correlation. If proven, this link may expand the scope of
chronic atherosclerotic impact in the brain.
We have hypothesized that the presence of intra-cranial
atherosclerosis can be an independent risk factor for cere-
bral atrophy. We have further hypothesized that this risk
can be age independent.
Methods
Subjects
Institutional Review Board approved for this retrospective
study without requirement for a patient consent. From the
stroke database of our institution, we included 68 consec-
utive patients from January 1, 2001 to December 31,
2003. These patients presented with acute stroke-like
symptoms to the emergency room and had [1] diagnostic
quality head CT and brain MRI with diffusion imaging
within a week of each other, and [2] information about
cerebrovascular risk factors available on the hospital
information system. 3 patients were excluded due to lack
of satisfactory imaging. Intracranial mass effects due to
large bleeds or infarcts and history of known malignancy
or dementia were additional exclusion criteria. There were
65 patients in the final study group including 34 (52%)




CT scans were performed on Siemens Volumetric Scan-
ners (Siemens Medical Solutions, Erlangen, Germany).
Bone window CT images (slice thickness 5 mm) through
the skull base were used to identify presence or absence of
carotid arterial calcifications (Figure 1) in the region of
each cavernous carotid (ICAC) artery by neuroradiologist
with 8 years experience in interpretation of neuroradio-
logical scans. The scoring is based on the thickness and
length of calcifications noted on carotid angiography.
Using this scheme (Table 1), calcifications in the cavern-
ous carotid arteries were assigned a number (1 to 4)) as
demonstrated in the attached calcium scoring table. The
average of the sum of right and left carotid calcium scores
was obtained to determine the final calcium score. The
final calcium scores were grouped into low (Grades I and
II) and high (Grades III and IV) calcium subtypes [16].
These subtypes of low and high calcium groups were plot-
ted against the average of the sum of central and cortical
atrophy scores. This separation into subgroups has con-
trasted the difference between high (heavy) and low (nil)
arterial calcium contents and has enabled us to test our
hypothesis between groups, for all practical purposes,
with and without arterial calcium.
MRI
MRI scans were performed on either a 1.5T magnet (Sym-
phony, Siemens Medical Solutions, Erlangen, Germany).
All patients went through a standard imaging protocol
including; T1-weighted (TR: 550–750 ms; TE: 20–25 ms;
5 mm scan thickness; slice gap: 5 mm; matrix: 256 × 256),
T2-weighted (TR: 4,000–5,000 ms; TE: 90–120 ms; 5 mm
scan thickness; slice gap: 5 mm; matrix: 256 × 256), Fluid
attenuation inversion recovery (FLAIR) (TR: 9000 ms; TE:
100 ms; TI: 2400 ms; 5 mm scan thickness; slice gap: 5
mm; matrix: 192 × 256), and diffusion weighted images.
Diffusion images were reconstructed as diffusion maps
(b0 1000) and ADC maps.
A neuroradiologist with 12 years of experience analyzed
MRI images independently and without the prior knowl-
edge of CT results or risk factor profile.
Periventricular hyperintensity (PVH) is graded based on
the visual scale as outlined in the cardiovascular health
study design [18,19].
The degree of cortical (Figure 2) and central atrophy (Fig-
ure 3) was graded by ventricular and sulcal dilatation
respectively on T1-Weighted images. The central and cor-
tical atrophy grading systems adopted from Cardiovascu-
lar Health Study was ranging from 1 (minimal) to 10
(maximum) [18,19]. The right and left sided scores wereBMC Neurology 2008, 8:51 http://www.biomedcentral.com/1471-2377/8/51
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Axial bone window images at the level of the cavernous sinuses for different grades of arterial calcium Figure 1
Axial bone window images at the level of the cavernous sinuses for different grades of arterial calcium. LOW 
CALCIUM SUBGROUP. A: Grade 1: Bilateral grade 1 cavernous carotids. Tangible arterial calcifications. B: Grade 2: Bilateral 
grade 2 cavernous carotids due to thin scattered calcifications. HIGH CALCIUM SUBGROUP. C: Grade 3: Bilateral grade 3 
calcifications. Thick, interrupted on the right and thin confluent on the left. D: Grade 4: Bilateral grade 4 ICAC seen as thick, 
contiguous calcifications.
A   C  
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averaged to obtain final atrophy score for central and cor-
tical atrophy patterns.
Cerebrovascular Risk factors
The cerebrovascular risk factors included hypertension,
hypercholesterolemia, diabetes, atrial fibrillation, history
of coronary artery disease and history of stroke.
Hypertension was defined as diagnosis by a physician,
history of treatment with anti-hypertensive medication,
systolic blood pressure above 150 mm of Hg and diastolic
blood pressure above 95 mm of Hg. Hypercholestero-
lemia was defined as blood cholesterol level greater than
240 mmol/dl. Diabetes was defined as diagnosis by a phy-
sician, history of anti-diabetic medication or fasting blood
sugar level greater than140 mmol/dl. Atrial fibrillation
was considered present if the patient had a history of it or
was being treated for it. Coronary artery disease was con-
sidered present if the patient had history of unstable
angina, myocardial infarction, coronary angioplasty or
coronary artery bypass surgery. History of previous stroke
was considered to be present if stroke was diagnosed pre-
viously by a physician.
Cerebral Ischemia Scores
Final cerebral ischemic damage is evaluated for periven-
tricular hyperintensity (PVH) and infarcts. PVH is visually
graded on FLAIR images (not shown) as outlined in cardi-
ovascular health study [18,19].
Based on the imaging criteria specified elsewhere [16]; the
cerebral infarcts have been divided into acute versus
chronic and small versus large vessel infarcts.
Statistical Analysis
The subjects were stratified into two groups, those with
high and low ICAC, respectively. Summary statistics
included means ± (standard deviations) for continuous
risk factors such as age, and counts and proportions for
the remaining discrete risk factors such as sex, hyperten-
sion, diabetes mellitus, cholesterol, coronary artery dis-
ease, history of stroke and atrial fibrillation.
The primary statistical hypothesis test postulated that the
atherosclerosis can be a risk factor for cerebral atrophy.
The above cerebrovascular risk factors between the sub-
jects with high and low ICAC were correlated using a uni-
variate Chi-square test. The mean age was compared by a
two-sample t-test between these two ICAC groups.
The secondary hypothesis postulated that these factors
can also be age independent. Multivariate stepwise logis-
tic regression analysis was performed to determine the
association of each atrophy subtype with all risk factors
and cerebral ischemia scores combined.
For all hypothesis tests, a statistical significance was
reached when the p-value p = 0.05 as the cutoff threshold.
Statistical software used was SPSS.
Table 1: A Four-Point Grading Scale for CT ICC.
Grade I Absence or near absence of calcifications.
Grade II Tiny, scattered calcifications.
Grade III Either thick, interrupted calcifications or thin, confluent calcifications.
Grade IV Thick, contiguous calcifications.
Cortical atrophy grades from 1 to 5 on T1-Weighted images (Image based grading spectrum for cortical atrophy has extended  between 1 and 10, 10 being the largest degree of sulcal dilatation) Figure 2
Cortical atrophy grades from 1 to 5 on T1-Weighted images (Image based grading spectrum for cortical atro-
phy has extended between 1 and 10, 10 being the largest degree of sulcal dilatation).
       Grade 1                 Grade 2              Grade 3           Grade 4               Grade 5 BMC Neurology 2008, 8:51 http://www.biomedcentral.com/1471-2377/8/51
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Results
Based on the univariate analysis of the CT images for grad-
ing of cavernous carotid artery calcium content, 19 of 65
(29%) patients were stratified into the low calcium sub-
group and 46 (71%) patients were in the high calcium
subgroup. The patients in the high calcium group were
older (71.7 ± 11.1 vs. 47.3 ± 17.4; p < 0.001) and had
more commonly history of hypertension (p = 0.0001),
diabetes mellitus (p < 0.001), CAD (p < 0.001), history of
stroke (p = 0.01), and atrial fibrillation (p = 0.03). How-
ever, the difference between two groups for sex and cho-
lesterol was not statistically significant (Table 2).
The subjects in high calcium group had higher cortical
and central grades of atrophy compared to the subjects
without calcification (Table 3). These differences were sta-
tistically significant (p < 0.001).
There was an increased association for only acute small
vessel infarcts (p = 0.01) in the high calcium group. This
was age independent (p = 0.002). After age adjustment,
the other infarct types did not correlate with high calcium
scores (Table 4). PVH did not correlate with high calcium
scores.
According to the multivariate logistic regression analysis,
there was a strong correlation with age (p < 0.001) for
both cortical atrophy and central atrophy. After age
adjustment, high calcium scores did not correlate with
cortical atrophy (Tables 5). In contrast, for central atro-
phy, there was a significant correlation between central
atrophy and high calcium scores (p = 0.04) after adjust-
ment for age (Table 6). There was no correlation between
other cardiovascular or cerebrovascular risk factors and
either atrophy type.
Discussion
In conclusion, our study is unique to evaluate the role of
arterial calcium from CT as a measure of atherosclerosis
on cerebral atrophy patterns. We have found age inde-
pendent correlation between central atrophy and intracra-
nial atherosclerosis. This distinct link has to be further
substantiated in large, longitudinal studies. We have not
Central atrophy grades from 1 to 5 on T1-Weighted images (Image based grading spectrum for central atrophy has extended  between 1 and 10, 10 being the largest degree of ventricular dilatation) Figure 3
Central atrophy grades from 1 to 5 on T1-Weighted images (Image based grading spectrum for central atro-
phy has extended between 1 and 10, 10 being the largest degree of ventricular dilatation).
    Grade 1           Grade 2              Grade 3               Grade 4           Grade 5 
Table 2: Summary Statistics of Characteristics and Cerebrovascular Risk Factors
Demographics/Risk Factors All Subjects (n = 65) Subjects with High Calcium 
(n = 46)
Subjects with Low Calcium 
(n = 19)
P-value
Age (mean +- SD) 64.6 +/- 17.2 71.7 +/- 11.1 47.3 +/-17.4 < 0.001
Sex (male) (%) 34 (52%) 26 (57%) 8 (42%) Not Significant
Hypertension (%) 40 (62%) 37 (80%) 3 (16%) < 0.001
Diabetes Mellitus (%) 15 (23%) 15 (33%) 0 (0%) < 0.001
Cholesterol (%) 41 (48%) 23 (50%) 8 (42%) Not Significant
Coronary Artery Disease (%) 22 (34%) 21 (47%) 1 (5%) < 0.001
History of Stroke (%) 22 (34%) 20 (44%) 2 (11%) 0.007
Atrial Fibrillation (%) 14 (22%) 13 (28%) 1 (5%) 0.03BMC Neurology 2008, 8:51 http://www.biomedcentral.com/1471-2377/8/51
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found any correlation between intracranial atherosclero-
sis and cortical atrophy.
Age is the most dominant determinant of cerebral
atrophic changes [4]. Recognizing the factors that acceler-
ate rates of cerebral atrophic and degenerative changes is
important because they may predispose to cognitive
declines. More importantly, the treatment or controlling
these noxious factors may reverse the course of the process
as reported in abstaining from alcohol [5].
There is an agreement in the literature for existence of cor-
tical and central atrophy subtypes in the supratentorial
brain. Different quantitative analysis indices have been
developed and utilized for these atrophy patterns [[1,2]
and [3]]. Our results support the existence of differential
cerebral atrophy types since we have found correlation
only between intracranial atherosclerosis and central atro-
phy. There is likely an intricate and rather complex rela-
tionship between these two subtypes of atrophy. For
example in age related global atrophy, there is more pro-
nounced central atrophy than cortical atrophy [20]. Addi-
tionally certain risk factors, such as alcohol or chronic
hemodialysis, may promote both types of these atrophy
patterns [1,5]. Interestingly in patients with dementia,
correlation has been reported with cortical [21] or central
atrophy [2] in different studies.
Cortical atrophy may have a pre-requisite of direct neuro-
nal loss as a result of noxious injury. Among the many
offending mechanisms, the most common source of this
type of atrophy, after old age, is probably Alzheimer's dis-
ease. Selective temporal and parietal cortical atrophy in
Alzheimer's is associated with diffuse neuronal depletion
in the involved cortical samples of these patients.
Although the cortical atrophy can be seen rarely as a static
phenomenon in the setting of mental retardation or in
patients with certain psychiatric conditions [22], in eld-
erly population, it can assume more dynamic component
in hippocampus with measurable annual volume loss.
These rates have been reported to be approximately 2.5
times greater in patients with AD than in individually age-
and gender-matched control subjects [21].
On the other hand, the central atrophy may reflect more
widespread changes in the parenchyma. Pathologic proc-
esses causing extensive demyelination without or with
neuronal damage may induce this pattern. It has been
claimed that central atrophy can be the measure of a total
tissue loss rather than index of focal demyelinating
lesions in MS [23]. Ischemic demyelination is the most
common form of chronic vasculopathy, typically related
to underlying hypertension. Therefore, it is not surprising
that in our study, we have found correlation between
intracranial atherosclerosis and central atrophy and with
acute small vessel infarcts but not with PVH. PVH has not
been associated with either atrophy type in our multivari-
ate analysis. Our results therefore may suggest a more
selective role of intracranial atherosclerosis on central
atrophy even in the absence of advanced leuko-araiosis.
With old age, leuko-araiosis may increase in a linear fash-
ion in both sexes [18] and cerebral perfusion decreases
[4,24]. In different studies, progressive leuko-araiosis
have correlated with cortical perfusion declines [24] and
central atrophy [4,20]. Our results are in favor of earlier
studies reporting association between central atrophy and
vascular dementia but not with pre-senile dementia [25].
The impact of degenerative cerebral changes evidenced by
neuroimaging studies on cognitive decline has not been
well understood. However incidence of diffuse cerebral
ischemic changes increases in the cognitively impaired
Table 3: Summary of Cortical and Ventricular Atrophy in Subjects with and without ICAC
Type of Calcification All Subjects (n = 65) Subjects with High Calcium 
(n = 46)
Subjects with Low Calcium 
(n = 19)
P-value
Cortical Atrophy 3.7 +/- 1.8 4.2 +/- 1.7 2.55 +/- 1.6 < 0.001
Central (ventricular) Atrophy 4.71 +/- 2.26 5.56 +/- 1.78 2.65 +/- 1.97 < 0.001
Table 4: Correlation of MRI Demonstrated Brain Infarct Subtypes with ICAC
Infarct Subtype Total Subjects n = 65 Subjects with High 
Calcium n = 46
Subjects with Low 
Calcium n = 19
P-value* P-value after an 
(adjustment for age, 
other risk factors) **
Acute SVI 17 16 1 0.01 0.002
Acute LVI 33 27 6 0.04 Not Significant
Chronic SVI 22 20 2 0.01 Not Significant
Chronic LVI 10 7 3 ns Not Significant
LVI – large vessel infarct, SVI – small vessel infarct
ICAC – Intracranial carotid artery calcificationBMC Neurology 2008, 8:51 http://www.biomedcentral.com/1471-2377/8/51
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groups; 12% in patients with no evidence of dementia,
32% in those with isolated memory loss, and 59% in
patients with possible or probable dementia. Throm-
boembolic rather than hemodynamic basis has been sug-
gested for pathogenesis of diffuse ischemia [3,26]. The
limitations exist for evaluating the role of atrophy indices
on cognition due to significant overlap being present
between measurable indices of cognitively intact and
declined populations. By reflecting more diffuse changes
in the cerebral parenchyma, central atrophy is more likely
to be associated with cognitive dysfunction [25,26].
Although associated with all types of atrophy, HIV and
alcohol are more likely to demonstrate central atrophy in
patients with cognitive dysfunction [[5,27,28] and [29]].
Similar observations have been made in the dementia
patients for whom central atrophy can predict cognitive
decline. In contrast, for their age matched non-demented
controls, the cortical atrophy is related to lower scores on
a cognitive test [3]. Our study lacks the data pertaining to
the cognitive status of our patients although there were no
patients with dementia. Future studies are needed in this
regard. We have observed similar results between intracra-
nial carotid arterial calcifications and central atrophy in a
small prospective study [30].
Conclusion
Cardiovascular risk factors such TIAs, hypertension,
smoking, hyperlipidemia, excessive alcohol consumption
and male gender may independently accelerate cerebral
atrophy and decrease cortico-subcortical perfusion per-
fusions [25]. Additional correlations have been reported
between diffuse cerebral ischemic changes and systolic
blood pressure, heart disease, peripheral vascular disease,
diabetes, focal neurological signs on examination and
central atrophy on CT [6,27]. Based on our results, intrac-
ranial atherosclerosis may emerge as a separate, age inde-
pendent risk factor for central atrophy. Correlation is also
independent of underlying cerebral ischemic changes as
identified by routine imaging studies. Interventions tar-
geting to control or to modify some of these cardiovascu-
lar risk factors and now, atherosclerosis should be
employed for those with accelerated cerebral atrophic and
degenerative changes identified by neuroimaging studies.
Accurate diagnosis of central atrophy can be hindered by
its mimickers on imaging studies however. This is espe-
cially valid for communicating or normal pressure hydro-
cephalus. Like central atrophy, these can also cause
ventricular dilatation. Subtle clues described for commu-
nicating hydrocephalus have to be identified by careful
analysis of sagittal midline T1-weighted images as distal
dilatation (funneling) of the aqueduct towards the fourth
ventricle (detected in 33.3% of these patients) and eleva-
tion of corpus callosum [31].
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